Purchase Order N3239824P0200
Award Date 2/1/24
Potential Completion Date 7/31/25
Potential Value $135K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
WPAFB, OH 45433, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian federal agency, to Health Research, Inc. (doing business as Health Research At Roswell Park), a non-profit organization. The contract, valued at $22,176.00, is for bioinformatics and biostatistical data analysis services to support the agency's work. No set-aside designation was used. Health Research At Roswell Park has a strong track record of executing federal research...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2) to Health Research, Inc. (doing business as Health Research At Roswell Park) to provide full bioinformatics and biostatistical data analysis services for the New Jersey Healthcare System's Lyons and East Orange campuses. The contract has a ceiling value of $22,298.83 and a period of performance through September 17, 2023. No set-aside designation was used for this award. Health Research At...
- This is a federal contract award made by the National Cancer Institute (NCI), a civilian agency, to Health Research, Inc. (HRI) Roswell Park Division. The $582,383.25 firm fixed-price delivery order contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ, and was awarded under the American Recovery and Reinvestment Act (ARRA) to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract does not have a...
- <p>The National Cancer Institute awarded a purchase order to Health Research, Inc. (Roswell Park Division) valued at $16,380.00 on June 4, 2019, for germline DNA samples and data from renal cell carcinoma patients to support the NCI's Renal Cell Carcinoma Genome-Wide Association Study. Work is performed in Buffalo, New York. The order carries a firm fixed price structure and a completion date of December 3, 2020.</p>
- The federal contract award is for a "Patterns of Care/Quality of Care Study (POC): Diagnosis Year 2016" to be performed by the Fred Hutchinson Cancer Research Center, a non-profit organization. The contract has a ceiling value of $75,367.00 and was awarded on July 31, 2017 by the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract is a firm fixed price delivery order, with an ultimate completion date of July 30, 2018. This...
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to Physical Sciences Inc. (PSI), a for-profit research and development company. The $198,397.00 contract is a Small Business Innovation Research (SBIR) Program Phase I action, with a firm fixed price. The award date was September 24, 2010, and the ultimate completion date was January 23, 2012. PSI has extensive experience supporting government agencies through prime contracts, subcontracts, and...
- This is a Definitive Contract awarded by the National Cancer Institute, a civilian agency within the U.S. Government, to Redwire Space Technologies, Inc., a for-profit small business corporation. The contract, valued at $199,992.00, is for a Firm Fixed Price with a period of performance from September 30, 2010 to September 29, 2011. The contract has a "Total Small Business" set-aside designation. The contract appears to be focused on research and technology development in support of...
- This federal contract award was granted by the Shared Services Center, a civilian agency, to the Institute for Medical Research Inc. (IMR), a non-profit organization, on June 1, 2024. The $749,994.00 grant is for a research project titled "PROTECTION FROM COSMIC RADIATION" with a completion date of May 31, 2027. The contract is not set aside. IMR has a long history of participating in medical research projects, including studies related to prostate cancer, infectious diseases, and...
- This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute, a civilian agency, to Buffalo Biolabs, LLC, a small business, for the development of anticancer agents under the Small Business Innovation Research (SBIR) program. The award amount is $1,496,764.00 and the period of performance is until October 31, 2014. The contract is a Phase II SBIR action, which indicates it is for the continued development and testing of a promising technology that was previously funded under a...
- <p>The National Cancer Institute awarded a definitive contract to Pathrx, Inc. for biomedical basic research under SBIR Topic 309 Phase II on September 22, 2015, with a ceiling value of $977,245.04.</p> <p>The contract funds research on high-density RT-PCR arrays for cancer diagnosis and prognosis. Performance runs from September 22, 2015 through September 21, 2017, and is priced on a cost-plus-fixed-fee basis. Place of performance is Watertown, MA.</p>